Novagenetics Inc.
Records under this name other than patents Novagenetics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,431,132 | Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,625,555 | Recombinant human interferon-like proteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,867,482 | Recombinant human interferon-like proteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,868,151 | Recombinant human interferon-like proteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,234,022 | Recombinant human interferon-like proteins and method of treatment using them Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,982,028 | Recombinant human interferon-like proteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,538,565 | Method of treating diseases with recombinant human interferon-like proteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,425,895 | Recombinant human interferon-like proteins Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,067,548 | Fusion Proteins Having Mutated Immunoglobulin Hinge Region Formerly held In force · High confidence | In force | High confidence | |
| US 11,028,398 | Fusion Proteins Having Mutated Immunoglobulin Hinge Region Formerly held In force · Medium confidence | In force | Medium confidence |